摘要
目的:Mg2+对脑组织的细胞代谢和调节功能作用已受到重视,现研究颅脑外伤(TBI)后早期补充硫酸镁对TBI的治疗意义。方法:将94例重型TBI患者随机分为硫酸镁组(n=32)、硫酸镁+利多卡因组(n=32)及对照组(n=30),硫酸镁组除常规治疗外还给予硫酸镁2 g(16 mmol/L)稀释至100 ml于15 min内静脉推注,并以硫酸镁7.8 g(65 mmol/L)稀释至500 ml静脉滴注24 h;硫酸镁+利多卡因组,除了上述方法应用硫酸镁外,加用利多卡因12mg/(kg.h)静脉维持24 h;对照组不补充硫酸镁或利多卡因,其余治疗同其他组。检测所有患者入院当天及第3 d血镁水平、入院当天和入院第7 d的血神经元烯醇化酶(NSE)含量,6个月后以格拉斯哥结果评分(GCS)来评估各组治疗结果。结果:各组重型TBI患者在受伤后第7 d时的血NSE水平无显著差异,伤后6个月的GCS评分无显著差异。结论:未发现TBI后早期补充硫酸镁能明显改善重型TBI的治疗作用。
Objective:The regulatory effects of magnesium on cellular metabolism in brain tissue have been emphasized. The early use of magnesium sulfate (MgSO4 ) in the treatment of traumatic brain injury (TBI). Methods: Ninety -four severe TBI patients were divided randomly into Groups A (MgSO4), B (MgSO4 + lidocaine) and C (normal control). Group A received 15 -minute intravenous injection of MgSO4 2 g ( 16 retool) diluted to 100ml, followed by 24 - hour intravenous interjection of MgSO4 7.8 g (65 mmol) diluted to 500 ml. Group B, in addition to the above administration, were given intravenous injection of lidocaine 1 mg/kg/h for 24 hours. We determined the level of blood Mg2 + at admission and 3 days after it and plasma neurone specific enolase (NSE) at admission and 1 week after injury, and conducted Glasgow Outcome Scale (GOS) assessment 6 months after injury for all the patients. Results : The 1 - week plasma NSE level and 6 - month GOS showed no significant statistical differences among different groups of patients. Conclusion: Our study failed to reveal apparent improvement in the severe TBI patients after early administration of MgSO4.
出处
《医学研究生学报》
CAS
2009年第5期490-492,共3页
Journal of Medical Postgraduates
基金
上海市浦东新区社会发展局卫生科技发展基金资助项目(批准号:Pw2004A-16)